Literature DB >> 24863959

Fetal skeletal dysplasias in a tertiary care center: radiology, pathology, and molecular analysis of 112 cases.

E Barkova1, U Mohan, D Chitayat, S Keating, A Toi, J Frank, R Frank, G Tomlinson, P Glanc.   

Abstract

Fetal skeletal dysplasias are a heterogeneous group of rare genetic disorders, affecting approximately 2.4-4.5 of 10,000 births. We performed a retrospective review of the perinatal autopsies conducted between the years 2002-2011 at our center. The study population consisted of fetuses diagnosed with skeletal dysplasia with subsequent termination, stillbirth and live-born who died shortly after birth. Of the 2002 autopsies performed, 112 (5.6%) were diagnosed with skeletal dysplasia. These 112 cases encompassed 17 of 40 groups of Nosology 2010. The two most common Nosology groups were osteogenesis imperfecta [OI, 27/112 (24%)] and the fibroblast growth factor receptor type 3 (FGFR3) chondrodysplasias [27/112 (24%)]. The most common specific diagnoses were thanatophoric dysplasia (TD) type 1 [20 (17.9%)], and OI type 2 [20 (17.9%)]. The combined radiology, pathology, and genetic investigations and grouping the cases using Nosology 2010 resulted in a specific diagnosis in 96 of 112 cases.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autopsy; fetal musculoskeletal dysplasia; molecular analysis; osteochondrodysplasia; pathology; prenatal diagnosis; radiology; skeletal dysplasias

Mesh:

Year:  2014        PMID: 24863959     DOI: 10.1111/cge.12434

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

Review 1.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

2.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

Review 3.  Ultrasound diagnosis of fetal thanatophoric skeletal dysplasia: Three cases report and a brief review.

Authors:  Qing-Hong Zhao; Hua Shi; Jia-Qi Hu; Dan Wang; Gui Fang; Yu-Guo Zhang; Yan-Qing Wang; Jing Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

4.  Challenges in Diagnosing Rare Genetic Causes of Common In Utero Presentations: Report of Two Patients with Mucolipidosis Type II (I-Cell Disease).

Authors:  Gregory Costain; Michal Inbar-Feigenberg; Maha Saleh; Shimrit Yaniv-Salem; Greg Ryan; Eric Morgen; Elaine S Goh; Gen Nishimura; David Chitayat
Journal:  J Pediatr Genet       Date:  2018-03-09

5.  Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta.

Authors:  Jerry K Y Chan; Cecilia Götherström
Journal:  Front Pharmacol       Date:  2014-10-09       Impact factor: 5.810

6.  Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta.

Authors:  S Bellur; M Jain; D Cuthbertson; D Krakow; J R Shapiro; R D Steiner; P A Smith; M B Bober; T Hart; J Krischer; M Mullins; P H Byers; M Pepin; M Durigova; F H Glorieux; F Rauch; V R Sutton; B Lee; S C Nagamani
Journal:  Genet Med       Date:  2015-10-01       Impact factor: 8.822

7.  Ossification center of the humeral shaft in the human fetus: a CT, digital, and statistical study.

Authors:  Marcin Wiśniewski; Mariusz Baumgart; Magdalena Grzonkowska; Bogdan Małkowski; Arnika Wilińska-Jankowska; Zygmunt Siedlecki; Michał Szpinda
Journal:  Surg Radiol Anat       Date:  2017-03-29       Impact factor: 1.246

8.  Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia).

Authors:  Dina Nadyrshina; Aliya Zaripova; Anton Tyurin; Ildar Minniakhmetov; Ekaterina Zakharova; Rita Khusainova
Journal:  Genes (Basel)       Date:  2022-01-10       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.